| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 772.29B | 671.21B | 564.09B | 557.41B | 433.83B |
| Gross Profit | 110.94B | 72.42B | 75.73B | 65.28B | 60.37B |
| EBITDA | 54.69B | 30.12B | 45.22B | 31.24B | 32.45B |
| Net Income | 11.14B | 2.23B | 6.52B | 6.13B | 11.51B |
Balance Sheet | |||||
| Total Assets | 636.93B | 596.56B | 480.27B | 475.58B | 421.29B |
| Cash, Cash Equivalents and Short-Term Investments | 46.81B | 70.62B | 27.49B | 19.00B | 15.93B |
| Total Debt | 281.10B | 290.17B | 137.12B | 179.48B | 152.16B |
| Total Liabilities | 392.45B | 382.04B | 235.98B | 264.59B | 231.79B |
| Stockholders Equity | 240.16B | 210.50B | 232.19B | 202.82B | 186.38B |
Cash Flow | |||||
| Free Cash Flow | 28.43B | -71.82B | 33.29B | -10.81B | -14.57B |
| Operating Cash Flow | 54.84B | -50.63B | 48.24B | 7.59B | 3.54B |
| Investing Cash Flow | -46.85B | -21.74B | 8.80B | -16.49B | -18.81B |
| Financing Cash Flow | -38.59B | 114.93B | -50.01B | 9.80B | 9.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥556.16B | 28.74 | 9.28% | 1.30% | 5.86% | -17.47% | |
69 Neutral | ¥552.78B | 18.49 | ― | 3.15% | 1.59% | -3.14% | |
69 Neutral | ¥21.03B | 20.45 | ― | 2.54% | 5.51% | 386.06% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | ¥168.88B | 7.50 | 12.56% | 3.44% | 4.40% | 91.05% | |
58 Neutral | ¥65.52B | 14.05 | ― | 3.77% | -1.82% | -32.12% | |
51 Neutral | ¥311.96B | 27.71 | ― | 1.45% | 15.06% | 399.49% |